PEGylated carboxyhemoglobin bovine (SANGUINATE) ameliorates myocardial infarction in a rat model. by Prolong Pharma | Dec 1, 2018 | Publications
Early Experiences With PEGylated Carboxyhemoglobin Bovine in Anemic Jehovah’s Witnesses: A Case Series and Review of the Literature. by Prolong Pharma | Dec 1, 2018 | Publications
PEGylated carboxyhemoglobin bovine (SANGUINATE) ameliorates myocardial infarction in a rat model. by Prolong Pharma | Dec 1, 2018 | Publications
Current and Novel Preventive and Curative Interventions for the Treatment of Patients with Sickle Cell Disease by Prolong Pharma | Oct 1, 2018 | Conferences
Investigational use of PEGylated carboxyhemoglobin bovine in a Jehovah’s Witness with hemorrhagic shock by Prolong Pharma | Oct 1, 2018 | Publications